• About Us
    • Board of Directors
    • Advisors
    • Committees
    • Staff
  • Our Work
    • In The News
    • Newsletter Archive
  • Programs
    • Scholarship Program
  • Join Now
    • Veterinary Professional
    • Pet Parents
    • Product Industry
    • Login
  • Directory of Practitioners
  • Get Involved
    • Make A Donation
    • Become A Corporate Sponsor
    • Join Email List
  • Contact
  • DONATE
  • Members Dashboard
Veterinary Cannabis SocietyVeterinary Cannabis Society
  • About Us
    • Board of Directors
    • Advisors
    • Committees
    • Staff
  • Our Work
    • In The News
    • Newsletter Archive
  • Programs
    • Scholarship Program
  • Join Now
    • Veterinary Professional
    • Pet Parents
    • Product Industry
    • Login
  • Directory of Practitioners
  • Get Involved
    • Make A Donation
    • Become A Corporate Sponsor
    • Join Email List
  • Contact
  • DONATE
  • Members Dashboard

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

Home Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

Curated Research Library

  • Back to Curated Research Library

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

  • By: Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN
  • Published On: 3 February, 2016
  • Publication: pubmed
  • Tags: general
  • Category: Osteoarthritis

Background: Current arthritis treatments often have side-effects attributable to active compounds as well as route of administration. Cannabidiol (CBD) attenuates inflammation and pain without side-effects, but CBD is hydrophobic and has poor oral bioavailability. Topical drug application avoids gastrointestinal administration, first pass metabolism, providing more constant plasma levels.

Methods: This study examined efficacy of transdermal CBD for reduction in inflammation and pain, assessing any adverse effects in a rat complete Freund’s adjuvant-induced monoarthritic knee joint model. CBD gels (0.6, 3.1, 6.2 or 62.3 mg/day) were applied for 4 consecutive days after arthritis induction. Joint circumference and immune cell invasion in histological sections were measured to indicate level of inflammation. Paw withdrawal latency (PWL) in response to noxious heat stimulation determined nociceptive sensitization, and exploratory behaviour ascertained animal’s activity level.

Results: Measurement of plasma CBD concentration provided by transdermal absorption revealed linearity with 0.6-6.2 mg/day doses. Transdermal CBD gel significantly reduced joint swelling, limb posture scores as a rating of spontaneous pain, immune cell infiltration and thickening of the synovial membrane in a dose-dependent manner. PWL recovered to near baseline level. Immunohistochemical analysis of spinal cord (CGRP, OX42) and dorsal root ganglia (TNFα) revealed dose-dependent reductions of pro-inflammatory biomarkers. Results showed 6.2 and 62 mg/day were effective doses. Exploratory behaviour was not altered by CBD indicating limited effect on higher brain function.

Conclusions: These data indicate that topical CBD application has therapeutic potential for relief of arthritis pain-related behaviours and inflammation without evident side-effects.

Click Here to Access Article
  • Back to Curated Research Library
Search

Our Mission is to create lasting solutions that ensure the safe use of cannabis in pets through education, advocacy, and promoting product standards.

Our Vision is an educated and empowered global veterinary medical cannabis community.

  • About Us
  • Our Work
  • Members Area
  • Get Involved
  • Contact Us
  • Donate

Email:
Click here to email us

Florida Mailing Address
7901 4th St. North, Suite 4404
St. Petersburg, FL 33702

California Mailing Address
4382 Piedmont Avenue
Oakland, CA 94611

Veterinary Cannabis Society is a nonprofit, 501(c)(3) organization in the United States. Tax ID #85-0986090

Veterinary Cannabis Society does not endorse any specific products.

© 2023 · Veterinary Cannabis Society

  • Terms of Use
  • Privacy Policy
  • State Notices
  • Contact